A Test Before An Approved Therapy: Inbiomotion MAFTEST Is Tackling Breast Cancer Metastases
Executive Summary
Bisphosphonate drugs, commonly prescribed to treat osteoporosis, have been linked to a reduction in breast cancer metastases in women. Inbiomotion is developing a test to expand the population eligible for this adjuvant therapy.
You may also be interested in...
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.
Deals Shaping The Industry, February 2024
An interactive look at pharma, medtech, and diagnostics deals made during February 2023. Data courtesy of Biomedtracker.
Execs On The Move: February 2024
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.